Context-Dependent Cell Cycle Checkpoint Abrogation by a Novel Kinase Inhibitor
Andrew J. Massey(Granta Design (United Kingdom)), Lee Walmsley(Granta Design (United Kingdom))
Cited by 12
Related Papers
Chk1 Inhibition as a novel therapeutic strategy for treating triple-negative breast and ovarian cancers
|BMC Cancer|2014|110
Inhibition of the checkpoint kinase Chk1 induces DNA damage and cell death in human Leukemia and Lymphoma cells
|Molecular Cancer|2014|53
Multiparametric Cell Cycle Analysis Using the Operetta High-Content Imager and Harmony Software with PhenoLOGIC
|PLoS ONE|2015|46